The Ecosystem: Oxford accelerator proposes a new model for commercialising rare disease therapies

Forty new rare disease programmes entering the clinic over the next decade. This is the goal of a new collaboration between Oxford University and the Harrington Discovery Institute, which aims to put up to £200M into getting projects out academic labs and into clinical development